1-7 of 7
Søren Lykke Petersen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of Pre-Transplantation Plasma ST2 Levels As a Prognostic Marker of 1-Year Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation

Lars Klingen Gjaerde, Sisse Rye Ostrowski, Frederikke Schierbeck, Niels Smedegaard Andersen, Lone Smidstrup Friis, Brian Thomas Kornblit, Søren Lykke Petersen, Ida Schjødt, Henrik Sengeloev
Journal: Blood
Blood (2021) 138 (Supplement 1): 3951.
https://doi.org/10.1182/blood-2021-144802
Published: 2021
Journal Articles

Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation

Lia Minculescu, Joanne Reekie, Søren Lykke Petersen, Brian Thomas Kornblit, Ida Schjødt, Niels Smedegaard Andersen, Lisbeth Pernille Andersen, Anne Fischer-Nielsen, Eva Kannik Hastrup, Lone Smidstrup Friis, Henrik Sengeloev
Journal: Blood
Blood (2021) 138 (Supplement 1): 2810.
https://doi.org/10.1182/blood-2021-148553
Published: 2021
Journal Articles

Pre-Transplantation ST2 Levels and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation

Lars Klingen Gjærde, MD, Sisse Rye Ostrowski, MD PhD DMSc, Ass Prof, Niels Smedegaard Andersen, MD PhD DMSc, Lone Smidstrup Friis, MD PhD, Brian Kornblit, MD PhD, Søren Lykke Petersen, MD DMSc, Ida Schjødt, MD PhD, Henrik Sengeløv, MD DMSc, Prof
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-133876
Published: 2020
Journal Articles

Improved Relapse-Free Survival and Overall Survival in Patients with High Immune Reconstitution of Gamma Delta T Cells 2 Months after Allogeneic Hematopoietic Stem Cell Transplantation

Lia Minculescu, MD, Hanne Vibeke Marquart, MD PhD, Lars Peter Ryder, MSc, PhD, Ida Schjødt, MD PhD, Lone Smidstrup Friis, MD PhD, Brian Thomas Kornblit, MD PhD, Søren Lykke Petersen, MD DMSc., Niels Smedegaard Andersen, MD PhD, Eva Kannik Hastrup, MD PhD, Anne Fischer-Nielsen, MD PhD, Henrik Sengeloev, MD DMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3396.
https://doi.org/10.1182/blood-2018-99-111777
Published: 2018
Journal Articles

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

Brenda M Sandmaier, MD, David G Maloney, MD PhD, Barry E. Storer, PhD, Gitte Olesen, MD, Michael B. Maris, MD, Jonathan A Gutman, MD, Soren Lykke Petersen, MD DMSC, Amelia Langston, MD, Thomas Chauncey, Wolfgang Bethge, MD, Michael A Pulsipher, MD, Brian Thomas Kornblit, MD PhD, Ann E Woolfrey, MD, Marco Mielcarek, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD, Rainer F. Storb, MD
Journal: Blood
Blood (2016) 128 (22): 506.
https://doi.org/10.1182/blood.V128.22.506.506
Published: 2016
Journal Articles

Association of HMGB1 Polymorphisms with Outcome After Allogeneic Hematopoietic Cell Transplantation.

Brian Kornblit, MD, Tania Nicole Masmas, MD, Søren Lykke Petersen, Hans O Madsen, Carsten Heilmann, Lone Schejbel, Henrik Sengeloev, Klaus Müller, Peter Garred, Lars Vindelov, MD
Journal: Blood
Blood (2009) 114 (22): 2260.
https://doi.org/10.1182/blood.V114.22.2260.2260
Published: 2009
Journal Articles

The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological Malignancy.

Tania N. Masmas, MD, Lennart Friis-Hansen, M.D., Jens Vilstrup Johansen, M.S., Soren Lykke Petersen, M.D., Brian T. Kornblit, M.D., Ole Winther, M.S., Finn Cilius Nielsen, M.D., Lars Vindelov, M.D.
Journal: Blood
Blood (2007) 110 (11): 1079.
https://doi.org/10.1182/blood.V110.11.1079.1079
Published: 2007